In Brief
This article was originally published in The Tan Sheet
Executive Summary
Equity investor buys into Schiff Nutrition
You may also be interested in...
Schiff Nutrition Gains Probiotics Ingredient, Brands From Ganeden
Schiff Nutrition International makes a $40 million investment in probiotic supplements by acquiring worldwide exclusive rights to the GanedenBC30 strain and a pair of consumer probiotics brands.
Schiff Nutrition Gains Probiotics Ingredient, Brands From Ganeden
Schiff Nutrition International makes a $40 million investment in probiotic supplements by acquiring worldwide exclusive rights to the GanedenBC30 strain and a pair of consumer probiotics brands.
Schiff Nutrition Gains Probiotics Ingredient, Brands From Ganeden
Schiff Nutrition International makes a $40 million investment in probiotic supplements by acquiring worldwide exclusive rights to the GanedenBC30 strain and a pair of consumer probiotics brands.